Affiliation:
1. Department of Nuclear Medicine, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China
2. Changzhou Key Laboratory of Molecular Imaging, Changzhou 213003, China
Abstract
(1) Background: To investigate the association between maximum standardized uptake value (SUVmax) based on 18F-FDG PET/CT and EGFR mutation status in lung adenocarcinoma. (2) Methods: A total of 366 patients were retrospectively collected and divided into the EGFR mutation group (n = 228) and EGFR wild-type group (n = 138) according to their EGFR mutation status. The two groups’ general information and PET/CT imaging parameters were compared. A hierarchical binary logistic regression model was used to assess the interaction effect on the relationship between SUVmax and EGFR mutation in different subgroups. Univariate and multivariate logistic regression was used to analyze the association between SUVmax and EGFR mutation. After adjusting for confounding factors, a generalized additive model and smooth curve fitting were applied to address possible non-linearities. (3) Results: Smoking status significantly affected the relationship between SUVmax and EGFR mutation (p for interaction = 0.012), with an interaction effect. After adjusting for age, gender, nodule type, bronchial sign, and CEA grouping, in the smoking subgroup, curve fitting results showed that the relationship between SUVmax and EGFR mutation was approximately linear (df = 1.000, c2 = 3.897, p = 0.048); with the increase in SUVmax, the probability of EGFR mutation gradually decreased, and the OR value was 0.952 (95%CI: 0.908–0.999; p = 0.045). (4) Conclusions: Smoking status can affect the relationship between SUVmax and EGFR mutation status in lung adenocarcinoma, especially in the positive smoking history subgroup. Fully understanding the effect of smoking status will help to improve the accuracy of SUVmax in predicting EGFR mutations.
Funder
Key Laboratory of Changzhou High-tech Research Project
Young Talent Development Plan of Changzhou Health Commission
Changzhou Science and Technology Program
Major Project of Changzhou Health Commission
Science and technology project of Changzhou Health Commission
Reference36 articles.
1. The biology and management of non-small cell lung cancer;Herbst;Nature,2018
2. Cancer statistics in China and United States, 2022: Profiles, trends, and determinants;Xia;Chin. Med. J.,2022
3. Role of EGFR mutations in lung cancers: Prognosis and tumor chemosensitivity;Suda;Arch. Toxicol.,2015
4. EGFR mutations and lung cancer;Shepherd;Annu. Rev. Pathol.,2011
5. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER);Shi;J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer,2014
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献